Skip to main content

Advertisement

SpringerLink
Log in

Airway hypersecretion in allergic rhinitis and asthma: New pharmacotherapy

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Mucus hypersecretion is a prominent feature of allergic rhinitis and asthma. Biologic targets for suppression of hypersecretion range from the inflammatory cells that initiate airway inflammation, to specific cellular elements such as calcium-activated chloride (CLCA) channels, epidermal growth factor receptor tyrosine kinase, and antiapoptotic factors (eg, Bcl-2). Identification of these targets is driving development of new pharmacotherapeutic compounds. Aside from specific instances in which a single mediator has a major impact on hypersecretion—for example, histamine in rhinitis—it is likely that compounds with broad-spectrum anti-inflammatory activity are more effective than compounds with restricted activity. However, certain highly specific targets, such as CLCA channels, seem to be intimately associated with development of a hypersecretory phenotype. Data from clinical trials with blockers of these targets are awaited with great interest, not only for disease management but also to determine the clinical benefit of selective inhibition of airway hypersecretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ferguson BJ: Allergic rhinitis: recognizing signs, symptoms, and triggering allergens. Postgrad Med 1997, 101:110–116.

    PubMed  CAS  Google Scholar 

  2. Liu YC, Khawaja AM, Rogers DF: Pathophysiogy of airway mucus secretion in asthma. In Asthma: Basic Mechanisms and Clinical Management, 3rd edn. Edited by Barnes PJ, Rodger IW, Thomson NC. London: Academic Press; 1998:205–227.

    Google Scholar 

  3. Passalacqua G, Ciprandi G, Canonica GW: The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 2001, 1:7–13. Excellent review describing the physiologic and pathophysiologic link between the nose and the lung, with an emphasis on epidemiologic evidence and the effects of treatment of allergic nasal conditions (rhinitis and sinusitis) and asthma.

    PubMed  CAS  Google Scholar 

  4. Knowles MR, Boucher RC: Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002, 109:571–577. Thoughtful consideration of the factors involved in effective mucus clearance in human lower airways that addresses two views of innate defense mechanisms in the airways.

    Article  PubMed  CAS  Google Scholar 

  5. Davies JR, Herrmann A, Russell W, et al.: Respiratory tract mucins: structure and expression patterns. In Mucus Hypersecretion in Respiratory Disease. Novartis Symposium Foundation 248. Chichester: John Wiley & Sons; 2002:76–88. Thorough overview of airway mucins by one of the world’s leading groups of mucin biochemists.

    Chapter  Google Scholar 

  6. Dekker J, Rossen JW, Buller HA, Einerhand AW: The MUC family: an obituary. Trends Biochem Sci 2002, 27:126–131.

    Article  PubMed  CAS  Google Scholar 

  7. Howarth PH, Salagean M, Dokic D: Allergic rhinitis: not purely a histamine-related disease. Allergy 2000, 55(Suppl_64):7–16. Excellent review of the pathophysiology of allergic rhinitis, with an emphasis on the cellular and molecular mechanisms underlying the generation of nasal inflammation and the production of clinical symptoms.

    Article  PubMed  Google Scholar 

  8. Mygind N: Nasal inflammation and anti-inflammatory treatment: semantics or clinical reality. Rhinology 2001, 39:61–65.

    PubMed  CAS  Google Scholar 

  9. Tai CF, Baraniuk JN: Upper airway neurogenic mechanisms. Curr Opin Allergy Clin Immunol 2002, 2:11–19.

    Article  PubMed  Google Scholar 

  10. Pelikan Z, Pelikan-Filipek M: Immediate nasal response to allergen challenge cytologic changes in the nasal secretions and histologic changes in the nasal mucosa. Adv Exp Med Biol 1995, 371B:847–853.

    PubMed  CAS  Google Scholar 

  11. Pelikan Z, Pelikan-Filipek M: Late nasal response to allergen challenge cytologic changes in the nasal secretions and histologic changes in the nasal mucosa. Adv Exp Med Biol 1995, 371B:855–860.

    PubMed  CAS  Google Scholar 

  12. Gluck U, Gebbers J: Epithelial changes in seasonal allergic rhinitis throughout the year: evidence of coexistent air pollution and local secretory IgA deficiency? ORL J Otorhinolaryngol Relat Spec 2000, 62:68–75.

    PubMed  CAS  Google Scholar 

  13. Bavbek S, Sencer H, Misirligil Z, et al.: Light and electron microscope study in allergic rhinitis patients (ARP) with or without bronchial hyperreactivity (BHR). J Investig Allergol Clin Immunol 1996, 6:172–182.

    PubMed  CAS  Google Scholar 

  14. Berger G, Marom Z, Ophir D: Goblet cell density of the inferior turbinates in patients with perennial allergic and nonallergic rhinitis. Am J Rhinol 1997, 11:233–236.

    PubMed  CAS  Google Scholar 

  15. Karlsson G, Pipkorn U: Natural allergen exposure does not influence the density of goblet cells in the nasal mucosa of patients with seasonal allergic rhinitis. Otorhinolaryngol Relat Spec 1989, 51:171–174.

    CAS  Google Scholar 

  16. Berger G, Moroz A, Marom Z, Ophir D: Inferior turbinate goblet cell secretion in patients with perennial allergic and nonallergic rhinitis. Am J Rhinol 1999, 13:473–477.

    PubMed  CAS  Google Scholar 

  17. Toppozada HH, Talaat MA: Tunica propria in chronic allergic rhinitis. Electron-microscopic study. I. The nasal blood vessels. J Otorhinolaryngol Relat Spec 1976, 38:86–92.

    CAS  Google Scholar 

  18. Mir-Salim PA, Merker HJ, Jahnke V, Berghaus A: [Glands of the human nasal mucosa-electron microscopy and immunohistochemical studies]. Laryngorhinootologie 1998, 77:322–327.

    PubMed  CAS  Google Scholar 

  19. Toppozada HH, Gaafar HA: Electron microscopy of the human nasal mixed glands. J Laryngol Otol 1973, 87:639–645.

    PubMed  CAS  Google Scholar 

  20. Takeuchi K, Yuta A, Sakakura Y: MUC2 mucin gene expression in the nose and maxillary sinus. Am J Otolaryngol 1995, 16:391–395.

    Article  PubMed  CAS  Google Scholar 

  21. Voynow JA, Selby DM, Rose MC: Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals. Lung 1998, 176:345–354.

    Article  PubMed  CAS  Google Scholar 

  22. Wood SJ, Birchall MA, Carlstedt I, Corfield AP: The expression of MUC5AC in allergic rhinitis. Biochem Soc Trans 1997, 25:504S.

    PubMed  CAS  Google Scholar 

  23. National Institutes of Health: Global Initiative for Asthma: pocket guide for asthma management and prevention. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; 2002: Publication no. 02-3659.

    Google Scholar 

  24. Eapen SS, Busse WW: Asthma. Clin Allergy Immunol 2002, 16:325–353.

    PubMed  CAS  Google Scholar 

  25. Rogers DF, Evans TW: Plasma exudation and oedema in asthma. Br Med Bull 1992, 48:120–134.

    PubMed  CAS  Google Scholar 

  26. Rogers DF: Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Monaldi Arch Chest Dis 2000, 55:324–332.

    PubMed  CAS  Google Scholar 

  27. Kirkham S, Sheehan JK, Knight D, et al.: Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002, 361:537–546.

    Article  PubMed  CAS  Google Scholar 

  28. Aust MR, Madsen CS, Jennings A, et al.: Mucin mRNA expression in normal and vasomotor inferior turbinates. Am J Rhinol 1997, 11:293–302.

    PubMed  CAS  Google Scholar 

  29. Rogers DF: Mucoactive drugs for asthma and COPD: Any place in therapy? Expert Opin Investig Drugs 2002, 11:15–35.

    Article  PubMed  CAS  Google Scholar 

  30. Holm AF, Fokkens WJ: Topical corticosteroids in allergic rhinitis; effects on nasal inflammatory cells and nasal mucosa. Clin Exp Allergy 2001, 31:529–535.

    Article  PubMed  CAS  Google Scholar 

  31. Dent G: Ciclesonide (Byk Gulden). Curr Opin Investig Drugs 2002, 3:78–83.

    PubMed  CAS  Google Scholar 

  32. Greiff L, Persson CG, Andersson M: Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Ann Allergy Asthma Immunol 2002, 89:413–418.

    PubMed  CAS  Google Scholar 

  33. Amichai B, Grunwald MH, Brenner L: Fexofenadine hydrochloride: a new anti-histaminic drug. Isr Med Assoc J 2001, 3:207–209.

    PubMed  CAS  Google Scholar 

  34. Kingham P: Carebastine Almirall Prodesfarma. Curr Opin Investig Drugs 2000, 1:90–96.

    PubMed  CAS  Google Scholar 

  35. Borish L: The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002, 88:16–22.

    PubMed  CAS  Google Scholar 

  36. Liu YC, Khawaja AM, Rogers DF: Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea pigs in vitro. Br J Pharmacol 1998, 124:563–571.

    Article  PubMed  CAS  Google Scholar 

  37. Shirasaki H, Kanaizumi E, Watanabe K, et al.: Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 2002, 32:1007–1012.

    Article  PubMed  CAS  Google Scholar 

  38. Storms WW: Rethinking our approach to allergic rhinitis management. Ann Allergy Asthma Immunol 2002, 88:30–35.

    PubMed  Google Scholar 

  39. Rogers DF: Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol 2002, 2:249–255.

    Article  PubMed  CAS  Google Scholar 

  40. Mullol J, Baraniuk JN, Logun C, et al.: M1 and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro. J Appl Physiol 1992, 73:2069–2073.

    PubMed  CAS  Google Scholar 

  41. Ramnarine SI, Haddad EB, Khawaja AM, et al.: On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 1996, 494:577–586.

    PubMed  CAS  Google Scholar 

  42. Nakaya M, Yuasa T, Usui N: Immunohistochemical localization of subtypes of muscarinic receptors in human inferior turbinate mucosa. Ann Otol Rhinol Laryngol 2002, 111:593–597.

    PubMed  Google Scholar 

  43. Pavia D, Sutton PP, Lopez-Vidriero MT, et al.: Drug effects on mucociliary function. Eur J Respir Dis Suppl 1983, 128:304–317.

    PubMed  Google Scholar 

  44. Hvizdos KM, Goa KL: Tiotropium bromide. Drugs 2002, 62:1195–1203.

    Article  PubMed  CAS  Google Scholar 

  45. Rubin BK: The pharmacologic approach to airway clearance: mucoactive agents. Respir Care 2002, 47:818–822.

    PubMed  Google Scholar 

  46. Poole PJ, Black PN: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001, 322:1271–1274.

    Article  PubMed  CAS  Google Scholar 

  47. Wright DT, Fischer BM, Li C, et al.: Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism. Am J Physiol 1996, 271:L854-L861.

    PubMed  CAS  Google Scholar 

  48. Rogers DF: Tachykinin receptor antagonists for asthma and COPD. Expert Opin Ther Patents 2001, 11:1097–1121.

    Article  CAS  Google Scholar 

  49. Spicuzza L, Haddad EB, Birrell M, et al.: Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves. Br J Pharmacol 2000, 130:1720–1726.

    Article  PubMed  CAS  Google Scholar 

  50. Caterina MJ, Julius D: The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24:487–517.

    Article  PubMed  CAS  Google Scholar 

  51. Pertwee RG: Cannabinoid receptors and pain. Prog Neurobiol 2001, 63:569–611.

    Article  PubMed  CAS  Google Scholar 

  52. Wills-Karp M: Trophic slime, allergic slime. Am J Respir Cell Mol Biol 2000, 22:637–639.

    PubMed  CAS  Google Scholar 

  53. Levine SJ, Larivee P, Logun C, et al.: Tumor necrosis factoralpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995, 12:196–204.

    PubMed  CAS  Google Scholar 

  54. Shim JJ, Dabbagh K, Takeyama K, et al.: Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000, 105:739–745.

    Article  PubMed  CAS  Google Scholar 

  55. Kanehiro A, Ikemura T, Makela MJ, et al.: Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 2001, 163:173–184.

    PubMed  CAS  Google Scholar 

  56. Schmidt BM, Kusma M, Feuring M, et al.: The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol 2001, 108:530–536.

    Article  PubMed  CAS  Google Scholar 

  57. Li Y, Martin LD, Spizz G, Adler KB: MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 2001, 276:40982–40990. Demonstration of a physiologic role for myristolated alanine-rich C kinase substrate as a key signaling molecule in mucin exocytosis from human epithelial cells.

    Article  PubMed  CAS  Google Scholar 

  58. Lee HM, Malm L, Dabbagh K, et al.: Epidermal growth factor receptor signaling mediates regranulation of rat nasal goblet cells. J Allergy Clin Immunol 2001, 107:1046–1050.

    Article  PubMed  CAS  Google Scholar 

  59. Nadel JA, Burgel PR: The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 2001, 1:254–258. Excellent review of the role of epidermal growth factor, its receptor and signaling pathways in mucus production, and goblet cell hyperplasia in the airways by the leading group in the field.

    Article  PubMed  CAS  Google Scholar 

  60. Sommerhoff CP, Caughey GH, Finkbeiner WE, et al.: Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989, 142:2450–2456.

    PubMed  CAS  Google Scholar 

  61. Clark JM, Abraham WM, Fishman CE, et al.: Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995, 152:2076–2083.

    PubMed  CAS  Google Scholar 

  62. Woodruff PG, Fahy JV: A role for neutrophils in asthma? Am J Med 2002, 112:498–500.

    Article  PubMed  Google Scholar 

  63. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990, 85:682–689.

    Article  PubMed  CAS  Google Scholar 

  64. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, et al.: Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol 1999, 20:729–736.

    PubMed  CAS  Google Scholar 

  65. Nadel JA, Takeyama K, Agusti C: Role of neutrophil elastase in hypersecretion in asthma. Eur Respir J 1999, 13:190–196.

    Article  PubMed  CAS  Google Scholar 

  66. Nogami H, Aizawa H, Matsumoto K, et al.: Neutrophil elastase inhibitor, ONO-5046 suppresses ozone-induced airway mucus hypersecretion in guinea pigs. Eur J Pharmacol 2000, 390:197–202.

    Article  PubMed  CAS  Google Scholar 

  67. Kellerman DJ: P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance. Chest 2002, 121(5 Suppl):201S-205S.

    Article  PubMed  CAS  Google Scholar 

  68. Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 1990, 141:72–78.

    PubMed  CAS  Google Scholar 

  69. Wales D, Woodhead M: The anti-inflammatory effects of macrolides. Thorax 1999, 54(Suppl 2):S58-S62.

    Article  PubMed  Google Scholar 

  70. Gorrini M, Lupi A, Viglio S, et al.: Inhibition of human neutrophil elastase by erythromycin and flurithromycin, two macrolide antibiotics. Am J Respir Cell Mol Biol 2001, 25:492–499.

    PubMed  CAS  Google Scholar 

  71. Wang B, Lim DJ, Han J, et al.: Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem 2002, 277:949–957.

    Article  PubMed  CAS  Google Scholar 

  72. Nakanishi A, Morita S, Iwashita H, et al.: Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 2001, 98:5175–5180.

    Article  PubMed  CAS  Google Scholar 

  73. Toda M, Tulic MK, Levitt RC, Hamid Q: A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 2002, 109:246–250. Building on evidence in animal models of asthma that CLCA channels are involved in generation of a hypersecretory phenotype, this research paper demonstrates that these channels are also upregulated and associated with the mucus hypersecretory phenotype in human asthma.

    Article  PubMed  CAS  Google Scholar 

  74. Tesfaigzi Y, Fischer MJ, Martin AJ, Seagrave J: Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1210-L1217. First demonstration of upregulation of the anti-apoptotic factor Bcl-2 in hyperplastic airway goblet cells in a model of allergic asthma.

    PubMed  CAS  Google Scholar 

  75. Bhattacharyya SN, Manna B, Smiley R, et al.: Smoke-induced inhalation injury: effects of retinoic acid and antisense oligodeoxynucleotide on stability and differentiated state of the mucociliary epithelium. Inflammation 1998, 22:203–214.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thoracic Medicine, National Heart & Lung Institute, Imperial College, Dovehouse St, SW3 6LY, London, UK

    Duncan F. Rogers PhD, FIBiol

Authors
  1. Duncan F. Rogers PhD, FIBiol
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogers, D.F. Airway hypersecretion in allergic rhinitis and asthma: New pharmacotherapy. Curr Allergy Asthma Rep 3, 238–248 (2003). https://doi.org/10.1007/s11882-003-0046-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-003-0046-1

Keywords

Search

Navigation